Purdue Pharma LP and Exicure Inc. have entered a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis.
The deal also covers R&D for other diseases amenable to a gene regulation approach utilizing Exicure's spherical nucleic acid (SNA)...








